LDN Social Media
Get connected with us on social networks
Dr Akbar Khan's LDN 2019 Conference Presentation
Low Dose Naltrexone (LDN) vs. Chemotherapy: One “Unproven” Therapy Against Another?
This lecture will describe some of the clinical trial evidence supporting well-accepted chemotherapy regimens for advanced cancers in adults, as well as some of the published human research about LDN. The audience will be challenged to decide if the “standard proven” therapies are actually better than LDN, which is still considered “unproven” by mainstream medicine.